(Date:11/24/2009)... Health care employment grew by ...only one to show consistent growth during the U.S....ls remain in trouble, and health systems are comin...el, instead of just administrators. , ...are employment continued growing in October despit...
(Date:11/24/2009)...HANGHAI,Nov.24/PRNewswire-Asia/--ShanghaiBiolaxyan...(SFDA)hasapprovedthe,investigationalnewdrugapplica...ativeinsulinformulationtotreatdiabetes.ThisIND,app...study. , Diabetesisadisordercharacteristicofh...ofdiabetesoftenresultinseveremicro-and,macro-vascu...
(Date:11/24/2009)...SXVENTURE:HTL , TORONTO,Nov.24/PRNewswire-Fir...ttoCapitalInc.,aleadingproviderofadvancedlasersyst...yclinicmarkets,todayreportedoperationalandfinancia..., ,Q32009Highlights,-Revenuewas$1.46millioncompar....3percentcomparedwith66.1percentinQ3,2008,-Netloss...
(Date:11/24/2009)...OZEN,Italy,November24/PRNewswire/--HealthRoboticst...urewithagroupofselected,investors.Thisrecentlyform...thRoboticsCanada,Inc.andwillmarket,install,andsupp...hincludesthe,revolutionaryproductofferingsi.v.STAT...adaInc.willalsoprovideassistanceonan"asneeded,basi...
Breaking Biology Technology:The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4Biolaxy Secures IND Approval for Oral Insulin 2Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2...sia-FirstCall/ -- Genesis,Pharmaceuticals Enterpri... the,"Company"), a U.S. pharmaceutical company wit...c of China, today announced its financial results ...ed December 31, 2008. , , Second Quarter of Fis...million, up 24.1% from the corresponding quarter, ...
...tech Industry , , FT. LAUDERDALE, Fla., Feb. 17 ...full-service securities broker-dealer and investme... Newbridge BioVentures Division ("NBV"). NBV is de...or the biotech industry and related investment opp...ividual investors. , , We are pleased to announce...
...ences, Inc. (Nasdaq: HGSI ) today announced that...ase 3 clinical trial program to evaluate the effic...glutide) in the long-term treatment of type 2 diab... million milestone payment in the first quarter of.../prnh/20080416/HGSLOGO ) , , "We are delighted t...
Other Biology Technology:Genesis Pharmaceuticals Reports Results for the Second Quarter of its Fiscal Year 2009 2Genesis Pharmaceuticals Reports Results for the Second Quarter of its Fiscal Year 2009 3Genesis Pharmaceuticals Reports Results for the Second Quarter of its Fiscal Year 2009 4Genesis Pharmaceuticals Reports Results for the Second Quarter of its Fiscal Year 2009 5Genesis Pharmaceuticals Reports Results for the Second Quarter of its Fiscal Year 2009 6Genesis Pharmaceuticals Reports Results for the Second Quarter of its Fiscal Year 2009 7Genesis Pharmaceuticals Reports Results for the Second Quarter of its Fiscal Year 2009 8Genesis Pharmaceuticals Reports Results for the Second Quarter of its Fiscal Year 2009 9Genesis Pharmaceuticals Reports Results for the Second Quarter of its Fiscal Year 2009 10Genesis Pharmaceuticals Reports Results for the Second Quarter of its Fiscal Year 2009 11Genesis Pharmaceuticals Reports Results for the Second Quarter of its Fiscal Year 2009 12Genesis Pharmaceuticals Reports Results for the Second Quarter of its Fiscal Year 2009 13Genesis Pharmaceuticals Reports Results for the Second Quarter of its Fiscal Year 2009 14Genesis Pharmaceuticals Reports Results for the Second Quarter of its Fiscal Year 2009 15Genesis Pharmaceuticals Reports Results for the Second Quarter of its Fiscal Year 2009 16Newbridge Securities Corporation Forms BioVentures Division 2Human Genome Sciences to Receive $9 Million Milestone Payment Related to GlaxoSmithKline Initiation of Phase 3 Clinical Trial of Syncria(R) in Type 2 Diabetes 2Human Genome Sciences to Receive $9 Million Milestone Payment Related to GlaxoSmithKline Initiation of Phase 3 Clinical Trial of Syncria(R) in Type 2 Diabetes 3Human Genome Sciences to Receive $9 Million Milestone Payment Related to GlaxoSmithKline Initiation of Phase 3 Clinical Trial of Syncria(R) in Type 2 Diabetes 4...r forum for health care executives to explore a my...aders. The 2008 Congress will include senior execu...argest employers, hospitals, health systems, healt... government. , One of the programs many highlight...re key health care advisors to Presidential hopefu...
...iversity have confirmed for the first time that a ...least the past 23 years and will likely remain the...fe in the area. , Steve DiMarco, associate profes...tudied dead zones in the Gulf of Mexico for more t...Texas coast extends from the Texas-Louisiana borde...
...omen use hormone replacement therapy (HRT) as a me... In a recent University of Missouri study, researc... synthetic progestin, could be a major factor in p...archers have compelling evidence that using an ant...tumors, or a small molecular drug, known as PRIMA,...
Other Biology News:5th Annual World Health Care Congress April 21-23, Washington, D.C. 2Researchers confirm dead zone off Texas coast since 1985 2MU researcher links hormone replacement therapy to breast cancer 2Sheep Anti-FLECAINIDE Polyclonal Antibody, Unconjugated from AbD Serotec
...or use in refrigerators, freezers, or liquid nitro...ks. Four vibrant colors allow for color coding to ... liquid nitrogen drainage or promote cool air circ...hich holds 81 tubes. Box dimensions: 13 x 13 x 5...
Rhesus Monkey IFN-Alpha from Cell Sciences
Rabbit Anti-HAX1 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Biology Products: